Drugs / NeoPep Vaccine2
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05557240 | Sep 2022 → Feb 2024 | malignant glioma | Shanghai 10th People's Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NeoPep Vaccine2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05557240 ↗ |
| Modality | Vaccine | “Patients will be repeatedly vaccinated with NPVAC2 drug products beginning on day 33 of the 6 maintenance TMZ cycle” NCT05557240 ↗ |